Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer cachexia.

M D Barber1, J A Ross, K C Fearon

  • 1University Department of Surgery, Royal Infirmary of Edinburgh, Scotland EH3 9YW, Edinburgh, UK.

Surgical Oncology
|December 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a single-visit protocol for the management of pregnancy of unknown location following in vitro fertilization: a retrospective study.

Human reproduction (Oxford, England)·2024
Same author

Myonuclear alterations associated with exercise are independent of age in humans.

The Journal of physiology·2023
Same author

On the survival of the quantum depletion of a condensate after release from a magnetic trap.

Scientific reports·2022
Same author

Trap frequency measurement with a pulsed atom laser.

Optics express·2022
Same author

Measurement of a helium tune-out frequency: an independent test of quantum electrodynamics.

Science (New York, N.Y.)·2022
Same author

The significance of low first trimester serum progesterone in ongoing early pregnancies presenting as pregnancies of unknown location.

European journal of obstetrics, gynecology, and reproductive biology·2021
Same journal

Comparative safety of postoperative HIPEC with recombinant mutant TNF-α versus paclitaxel for gastric cancer peritoneal metastasis: a randomized controlled trial.

Surgical oncology·2026
Same journal

Early postoperative hospital exposome stress, multisystem recovery trajectories, and long-term oncologic outcomes after curative colorectal cancer surgery.

Surgical oncology·2026
Same journal

Prognostic significance of age in adult primary intestinal diffuse large B-cell lymphoma: Insights from the SEER database.

Surgical oncology·2026
Same journal

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis of long-term outcomes.

Surgical oncology·2026
Same journal

Associations of latent profiles of resilience and fear of progression with discharge symptoms and postoperative frailty among patients undergoing lung resection: A longitudinal study.

Surgical oncology·2026
Same journal

Plastic surgeon or surgical oncologist: Impact of surgical training background on outcomes in microsurgical head and neck reconstruction.

Surgical oncology·2026
See all related articles

Cancer cachexia, marked by metabolic dysfunction and tissue loss, is a significant challenge. Combining metabolic normalization agents with nutritional support may offer a novel approach to combat this condition.

Area of Science:

  • Oncology
  • Metabolic Medicine
  • Nutritional Science

Background:

  • Cachexia significantly increases morbidity and mortality in advanced cancer patients.
  • It involves metabolic abnormalities like inefficient substrate utilization and altered energy balance, driven by inflammation and tumor factors.
  • This leads to detrimental loss of both fat and lean body mass.

Purpose of the Study:

  • To explore the potential of combined pharmacological and nutritional interventions to reverse cachexia in advanced cancer.
  • To address the limitations of conventional nutritional supplements in managing cancer cachexia.

Main Methods:

  • Review of existing research on cachexia pathophysiology and treatment approaches.
  • Analysis of the role of pro-inflammatory cytokines, neuro-endocrine axis, and tumor-derived factors.

Related Experiment Videos

  • Evaluation of pharmacological agents targeting metabolic abnormalities.

    • Main Results:

    • Conventional nutritional supplements have shown limited success due to underlying metabolic derangements.
    • Pharmacological agents have yielded only partial success in normalizing metabolic changes.
    • The combination of metabolic normalization and nutritional support presents a promising therapeutic strategy.

    Conclusions:

    • Cancer cachexia is a complex metabolic syndrome resistant to conventional treatments.
    • Targeting the metabolic abnormalities is crucial for effective cachexia management.
    • A combined approach of metabolic agents and nutritional support holds potential for reversing cachexia and improving patient outcomes.